122 related articles for article (PubMed ID: 38382852)
1. Left atrial structural and functional remodelling in Fabry disease and cardiac amyloidosis: A comparative analysis.
Meucci MC; Lillo R; Mango F; Marsilia M; Iannaccone G; Tusa F; Luigetti M; Biagini E; Massetti M; Lanza GA; Lombardo A; Graziani F
Int J Cardiol; 2024 May; 402():131891. PubMed ID: 38382852
[TBL] [Abstract][Full Text] [Related]
2. Left atrial enlargement and reduced atrial compliance occurs early in Fabry cardiomyopathy.
Boyd AC; Lo Q; Devine K; Tchan MC; Sillence DO; Sadick N; Richards DA; Thomas L
J Am Soc Echocardiogr; 2013 Dec; 26(12):1415-23. PubMed ID: 24094560
[TBL] [Abstract][Full Text] [Related]
3. Comparison of left atrial size and function in hypertrophic cardiomyopathy and in Fabry disease with left ventricular hypertrophy.
Saccheri MC; Cianciulli TF; Challapa Licidio W; Lax JA; Beck MA; Morita LA; Gagliardi JA;
Echocardiography; 2018 May; 35(5):643-650. PubMed ID: 29457264
[TBL] [Abstract][Full Text] [Related]
4. Left atrial strain imaging differentiates cardiac amyloidosis and hypertensive heart disease.
Rausch K; Scalia GM; Sato K; Edwards N; Lam AK; Platts DG; Chan J
Int J Cardiovasc Imaging; 2021 Jan; 37(1):81-90. PubMed ID: 32728989
[TBL] [Abstract][Full Text] [Related]
5. Impaired Left Atrial Function in Fabry Disease: A Longitudinal Speckle-Tracking Echocardiography Study.
Pichette M; Serri K; Pagé M; Di LZ; Bichet DG; Poulin F
J Am Soc Echocardiogr; 2017 Feb; 30(2):170-179.e2. PubMed ID: 27939050
[TBL] [Abstract][Full Text] [Related]
6. Left atrial structure and function in cardiac amyloidosis.
Nochioka K; Quarta CC; Claggett B; Roca GQ; Rapezzi C; Falk RH; Solomon SD
Eur Heart J Cardiovasc Imaging; 2017 Oct; 18(10):1128-1137. PubMed ID: 28637305
[TBL] [Abstract][Full Text] [Related]
7. Systolic and diastolic function assessment in fabry disease patients using speckle-tracking imaging and comparison with conventional echocardiographic measurements.
Shanks M; Thompson RB; Paterson ID; Putko B; Khan A; Chan A; Becher H; Oudit GY
J Am Soc Echocardiogr; 2013 Dec; 26(12):1407-14. PubMed ID: 24125876
[TBL] [Abstract][Full Text] [Related]
8. Left Atrial Morphology, Size and Function in Patients With Transthyretin Cardiac Amyloidosis and Primary Hypertrophic Cardiomyopathy - Comparative Strain Imaging Study.
de Gregorio C; Dattilo G; Casale M; Terrizzi A; Donato R; Di Bella G
Circ J; 2016 Jul; 80(8):1830-7. PubMed ID: 27350016
[TBL] [Abstract][Full Text] [Related]
9. Right heart and left atrial strain to differentiate cardiac amyloidosis and Fabry disease.
Mattig I; Steudel T; Klingel K; Barzen G; Frumkin D; Spethmann S; Romero Dorta E; Stangl K; Heidecker B; Landmesser U; Knebel F; Canaan-Kühl S; Hahn K; Brand A
Sci Rep; 2024 Jan; 14(1):2445. PubMed ID: 38291191
[TBL] [Abstract][Full Text] [Related]
10. Global cardiac alterations detected by speckle-tracking echocardiography in Fabry disease: left ventricular, right ventricular, and left atrial dysfunction are common and linked to worse symptomatic status.
Morris DA; Blaschke D; Canaan-Kühl S; Krebs A; Knobloch G; Walter TC; Haverkamp W
Int J Cardiovasc Imaging; 2015 Feb; 31(2):301-13. PubMed ID: 25315709
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of Left Atrial Deformation Parameters and Their Prognostic Impact in Patients with Pathological Left Ventricular Hypertrophy: Analysis by Speckle Tracking Echocardiography.
Iio C; Inoue K; Nishimura K; Fujii A; Nagai T; Suzuki J; Okura T; Higaki J; Ogimoto A
Echocardiography; 2015 Dec; 32(12):1821-30. PubMed ID: 25959698
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
[TBL] [Abstract][Full Text] [Related]
13. Difference in left atrial myocardial dynamics during reservoir phase between hypertrophic cardiomyopathy and hypertensive heart determined using three-dimensional speckle tracking echocardiography.
Yanagi Y; Okada K; Kaga S; Mikami T; Aiba M; Masauzi N; Murayama M; Tanemura A; Yokoyama S; Nishino H; Nakabachi M; Tamaki Y; Aoyagi H; Motoi K; Ishizaka S; Chiba Y; Tsujinaga S; Iwano H; Anzai T
Int J Cardiovasc Imaging; 2022 Aug; 38(8):1781-1791. PubMed ID: 37726515
[TBL] [Abstract][Full Text] [Related]
14. Phasic left atrial strain analysis to discriminate cardiac amyloidosis in patients with unclear thick heart pathology.
Brand A; Frumkin D; Hübscher A; Dreger H; Stangl K; Baldenhofer G; Knebel F
Eur Heart J Cardiovasc Imaging; 2021 May; 22(6):680-687. PubMed ID: 32243500
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of right ventricular strain in Fabry cardiomyopathy and sarcomeric hypertrophic cardiomyopathy.
Meucci MC; Lillo R; Lombardo A; Lanza GA; Bootsma M; Butcher SC; Massetti M; Manna R; Bax JJ; Crea F; Ajmone Marsan N; Graziani F
Eur Heart J Cardiovasc Imaging; 2023 Mar; 24(4):542-551. PubMed ID: 35900225
[TBL] [Abstract][Full Text] [Related]
16. Severe bradyarrhythmia linked to left atrial dysfunction in Fabry disease-A cross-sectional study.
Di LZ; Pichette M; Nadeau R; Bichet DG; Poulin F
Clin Cardiol; 2018 Sep; 41(9):1207-1213. PubMed ID: 29959806
[TBL] [Abstract][Full Text] [Related]
17. The value of myocardial work in patients with left ventricular hypertrophy.
Fan J; Ma C; Wang H; Zhou B
Int J Cardiovasc Imaging; 2023 Jun; 39(6):1105-1113. PubMed ID: 36922462
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of phasic left atrial strain and left ventricular posterolateral strain pattern to discriminate Fabry cardiomyopathy from other forms of left ventricular hypertrophy.
Frumkin D; Mattig I; Laule N; Al Daas M; Canaan-Kühl S; Knebel F; Stangl K; Brand A
Echocardiography; 2021 Nov; 38(11):1870-1878. PubMed ID: 34672387
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of left atrial mechanics in cardiac light-chain amyloidosis with preserved ejection fraction: a cohort study.
Liu XH; Shi JY; Zhang DD; Jia FW; Lin X; Zhu YL; Zhuang JL; Fang LG; Chen W
BMC Cardiovasc Disord; 2022 Apr; 22(1):175. PubMed ID: 35428181
[TBL] [Abstract][Full Text] [Related]
20. Yield of bone scintigraphy screening for transthyretin-related cardiac amyloidosis in different conditions: Methodological issues and clinical implications.
Tini G; Sessarego E; Benenati S; Vianello PF; Musumeci B; Autore C; Canepa M
Eur J Clin Invest; 2021 Dec; 51(12):e13665. PubMed ID: 34390490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
